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Abstract
Background: Cardiac mortality in Duchenne muscular dystrophy (DMD) has recently become important, because risk
of respiratory failure has been reduced due to widespread use of the respirator. The cardiac involvement is characterized
by distinctive electrocardiographic abnormalities or dilated cardiomyopathy, but the pathogenesis has remained obscure.
In research on DMD, Golden retriever-based muscular dystrophy (GRMD) has attracted much attention as an animal
model because it resembles DMD, but GRMD is very difficult to maintain because of their severe phenotypes. We
therefore established a line of dogs with Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ) and
examined the cardiac involvement.
Methods: The cardiac phenotypes of eight CXMDJ and four normal male dogs 2 to 21 months of age were evaluated
using electrocardiography, echocardiography, and histopathological examinations.
Results: Increases in the heart rate and decreases in PQ interval compared to a normal littermate were detected in two
littermate CXMDJ dogs at 15 months of age or older. Distinct deep Q-waves and increase in Q/R ratios in leads II, III,
and aVF were detected by 6–7 months of age in all CXMDJ dogs. In the echocardiogram, one of eight of CXMDJ dogs
showed a hyperechoic lesion in the left ventricular posterior wall at 5 months of age, but the rest had not by 6–7 months
of age. The left ventricular function in the echocardiogram indicated no abnormality in all CXMDJ dogs by 6–7 months
of age. Histopathology revealed myocardial fibrosis, especially in the left ventricular posterobasal wall, in three of eight
CXMDJ dogs by 21 months of age.
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Conclusion: Cardiac involvement in CXMDJ dogs is milder and has slower progression than that described in GRMD
dogs. The distinct deep Q-waves have been ascribed to myocardial fibrosis in the posterobasal region of the left ventricle,
but our data showed that they precede the lesion on echocardiogram and histopathology. These findings imply that
studies of CXMDJ may reveal not only another causative mechanism of the deep Q-waves but also more information on
the pathogenesis in the dystrophin-deficient heart.
Background
Duchenne muscular dystrophy (DMD) is a common and
lethal genetic disease characterized by progressive muscle
wasting. It is an X-linked recessive disorder caused by
mutations in the dystrophin gene, which encodes a
cytoskeletal protein, dystrophin [1]. The absence of dys-
trophin is accompanied by a loss of dystrophin-glycopro-
tein complex at the sarcolemma and results in progressive
degeneration of skeletal and cardiac muscle with fibrotic
tissue replacement and fatty infiltration [2,3]. The onset of
the disease occurs between 2 and 5 years of age, and most
patients die of respiratory or cardiac failure [4,5]. Cardiac
involvement, which occurs commonly in DMD patients,
has increasingly become an important cause of death
because recent clinical progress has reduced the risk of
death due to respiratory failure [6,7].
Like dystrophin-deficient skeletal muscle, dystrophin-
deficient cardiac muscle is replaced by fibrotic or fatty tis-
sue, especially in the left ventricular posterobasal wall
region [8-11]. Atrophic changes with loss of striation, vac-
uolation, fragmentation, or nuclear degeneration in the
myocardium have also been reported [12]. Progressive
involvement of the left ventricle leads to wall motion
abnormality and results in dilated cardiomyopathy. In
DMD patients, the electrocardiogram (ECG) may show
tall R-waves in the right precordial leads, deep Q-waves in
leads I, aVL, V5-6 or II, III, and aVF [8-13], as well as an
increased heart rate, shortened PQ (PR) interval, conduc-
tion abnormalities or arrhythmias such as sinus arrhyth-
mia, atrial ectopic beats, and ventricular premature
complexes in DMD patients [13-16]. One of the electro-
cardiographic abnormalities, deep Q-waves, has been
considered to be attributable to myocardial fibrosis
[8,9,17]. Echocardiography indicates myocardial thicken-
ing, wall motion abnormalities, enlargement of the left
ventricle, and left ventricular systolic and diastolic dys-
function. Hypokinesis of the posterobasal wall is consist-
ent with the spreading fibrosis and significant decrease in
the internal dimensions of the ventricles [14,15]. There
are, however, many unresolved issues in cardiac involve-
ment, such as the reason why the posterobasilar segment
of the left ventricle is consistently the first lesion, whether
extensive fibrosis involves the conduction system, the
pathogenesis of inappropriate tachycardia or electrocardi-
ographic abnormalities, and whether abnormal smooth
muscle regulation affects the cardiomyopathy [18]. One
way to clarify these problems is to study suitable animal
models.
To date, the X-linked muscular dystrophy (mdx) mouse
and the Golden retriever-based muscular dystrophy dog
(GRMD) have been used for elucidation of the pathogen-
esis and development of therapy for DMD. The pheno-
types of GRMD are more similar to DMD than that of the
mdx mouse [19-21], and GRMD also shows similar elec-
trocardiographic findings and progressive cardiomyopa-
thy comparable to the cardiac involvement of DMD
patients [20-23]. In this respect, GRMD is a useful model
to explore cardiac involvement, but GRMD is very difficult
to maintain because of their severe phenotypes. Mild phe-
notypes can be expected in small sized dogs such as Bea-
gle, indicated by the cross-bred study by Valentine et al.
[20]. Moreover, medium-sized Beagle is easy to handle or
raise than GRMD, therefore they have definite advantages
in animal housing or welfare. Therefore, we established a
Beagle-based dog colony named canine X-linked muscu-
lar dystrophy in Japan (CXMDJ) [24]. In CXMDJ, involve-
ment of the temporalis and limb muscles is observed from
2 months of age, and macroglossia, dysphagia, drooling,
and joint contracture are apparent from 4 months of age;
the phenotypes of CXMDJ are thus almost comparable to
GRMD [25]. In this study, we investigated the cardiac phe-
notypes in CXMDJ using electrocardiography, echocardi-
ography, and pathological examinations. Abnormalities
on echocardiogram and cardiac pathology were detected
from 12 months of age; however, the distinct deep Q-
waves in leads II, III, and aVF on ECG were consistently
observed by 6–7 months of age in all CXMDJ dogs exam-
ined. The cardiac phenotypes of CXMDJ were identical to
but milder than those of GRMD described in the litera-
ture. Thus, CXMDJ may also be a suitable animal model
for elucidation of the above-mentioned problems.
Methods
Animals
We imported frozen GRMD semen and artificially insem-
inated a Beagle bitch. The carriers produced were mated
with unrelated Beagles, and a Beagle-based canine X-
linked muscular dystrophy (CXMDJ) breeding colony was
established [24]. In this study, four normal male and eight
affected male dogs of the third generation (G3) between 2
to 21 months of age were examined. All of the affected
and normal dogs were descendents of a single affectedBMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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male, and were part of the CXMDJ breeding colony at the
General Animal Research Facility, National Institute of
Neuroscience, National Center of Neurology and Psychia-
try (NCNP) (Tokyo, Japan) or the Chugai Research Insti-
tute for Medical Science, Inc. (Nagano, Japan). The
clinical and histopathological characteristics, except for
cardiac involvement, of CXMDJ  dogs were recently
described [25]. These dogs were cared for and treated in
accordance with the guidelines provided by the Ethics
Committee for the Treatment of Laboratory Middle-Sized
Animals of the National Institute of Neuroscience, NCNP
(Tokyo, Japan) or the Ethics Committee for Treatment of
Laboratory Animal of Chugai Pharmaceutical Co., Ltd.
(Tokyo, Japan). These studies were also approved by the
Ethics Committee for the Treatment of Laboratory Mid-
dle-Sized Animals of NCNP (approved No. 13-03, 14-03,
15-03, 16-03, 17-03, and 18-03). All experiments were
performed with consideration for preventing unnecessary
pain.
Genotyping of CXMDJ allele
Each affected or normal male dog was identified by geno-
typing. A snapback method of single-strand conformation
polymorphism analysis was used to determine the GRMD
allele as described previously [26].
Measurement of serum creatine kinase (CK)
Blood samples were obtained from the cephalic vein at
sacrifice. Serum CK level was measured by colorimetric
assay using a FDC3500 clinical biochemistry analyzer
(FujiFilm Medical Co., Tokyo, Japan).
Electrocardiographic studies
Leads I, II, III, aVR, aVL and aVF were recorded in the right
lateral recumbency using an ECG-922 electrocardiograph
(Nihon Koden, Tokyo, Japan) [27]. All ECGs were
obtained at a paper speed of 50 mm/sec and calibration of
10 mm/mV. First, the electrocardiography were per-
formed in two CXMDJ (III-302MA, III-303MA) and one
normal littermate (III-301MN) dogs at 2, 3, 4, 6, 9, 12, 15,
18, and 21 months of age, and the heart rate (HR), inter-
vals of PQ and QRS, and Q/R ratios were measured. How-
ever, in normal control and in CXMDJ, Q waves were not
prominent in leads aVR and aVL, therefore, we measured
the Q/R ratios in leads I, II, III and aVF. Next, we com-
pared the HR, intervals of PQ and QRS, or Q/R ratios in I,
II, III and aVF in eight CXMDJ and four normal dogs at 6–
7 months of age.
Echocardiographic studies
M-mode and two-dimensional echocardiography was per-
formed using an EUB-8000 echocardiograph (Hitachi
Medical Corporation, Tokyo, Japan). The thickness of the
interventricular septum (IVS) and left ventricular poste-
rior wall (LVPW) at end-diastole, left ventricular internal
dimension at end-diastole (LVIDd) and systole (LVIDs),
and fractional shortening (FS) were examined on normal
and CXMDJ dogs using M-mode echocardiography. We
calculated the M-mode parameters based on multiple
measurements of 5 consecutive heart cycles, or 3 or 5 rep-
resentative heart cycles. We examined the parameters
mentioned above and myocardial echogenicity in two
CXMDJ (III-302MA, III-303MA) and one normal litter-
mate (III-301MN) dogs at 2, 3, 4, 6, 9, 12, 15, 18, and 21
months of age. We also examined the parameters men-
tioned above and myocardial echogenicity in six CXMDJ
(III-D53MA, III-D55MA, III-1803MA, III-D38MA, III-
D02MA, III-D08MA) and three normal dogs (III-D56MN,
III-1804MN, III-D03MN) at the time point just before
euthanasia. Among those dogs, myocardial echogenicity
in one CXMDJ (III-D02MA) and its normal littermate (III-
D03MN), and another CXMDJ (III-D08MA) dogs were
also examined at various time points.
Macroscopic and histopathological analyses
All dogs in this study underwent cardiac histological anal-
ysis. After a dog was given an overdose of intravenous
pentobarbital, the whole heart was removed and immedi-
ately fixed in 15% buffered formalin. Formalin-fixed
hearts were cross-sectioned, and samples were taken from
the right and left ventricles at the apical papillary muscle
and basal levels (each level containing the interventricular
septum, anterior wall, lateral wall, and posterior wall).
The tissue blocks were embedded in paraffin, and 10 μm
sections were stained with hematoxylin and eosin or Mas-
son's trichrome stain. Photographs were taken with a DAS
Mikroskop LEITZ DMRB microscope (Leica, Wetzlar, Ger-
many), using a digital still camera system HC-2500 (Fuji-
Film, Tokyo, Japan).
Statistics
Data are expressed as means +/- SE. Student's t test was
used to evaluate differences between the two groups. A p
value of less than 0.05 was considered to indicate statisti-
cal significance.
Results
Clinical profiles of CXMDJ
We recently reported the detailed clinical and histopatho-
logical characteristics of CXMDJ except for cardiac pheno-
types [25]. None of the dogs in the present study showed
clinical signs of heart failure, and no murmur was present
on auscultation in any CXMDJ dog examined. We evalu-
ated body and heart weight, the ratio of heart to body
weight, and serum CK in eight CXMDJ and four normal
male dogs aged 6–21 months just before euthanasia
(Table 1). There were no differences in body and heart
weight and heart/body weight ratio between normal and
CXMDJ dogs. Serum CK levels in the CXMDJ dogs ranged
from 12,500 to 13 8,000 IU/1. These values were signifi-BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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cantly different from those in normal control dogs (60 to
515 IU/1). One 9-month-old CXMDJ dog, III-D55MA, did
not show any signs of respiratory or cardiac failure. When
we tried to record a routine ECG of the dog, the dog strug-
gled to escape from recording and then ceased moving.
Immediately afterwards, we recorded ECG and the moni-
tor showed an idioventricular rhythm. The dog died
despite attempted cardiopulmonary resuscitation.
Electrocardiographic findings
The HR and PQ intervals of the affected littermates were
no different from those recorded from a normal littermate
at 12 months of age, but we detected an increase in HR
and a decrease in PQ interval in the affected dogs after 15
months of age (Fig. 1A). The HR and PQ intervals were
negatively correlated both in normal and affected dogs
(data not shown). The QRS interval in the affected dogs
did not differ from that in the normal littermate at any age
(Fig. 1A). Prominent deep Q-waves were observed in limb
leads II, III, and aVF in some CXMDJ dogs, but not in the
normal littermates, as shown in Fig. 1B. The Q/R ratios
were definitely increased in the affected littermates at 6
months of age or older compared with the normal litter-
mate (Fig. 1C). In all normal and CXMDJ dogs at 6–7
months of age, the HR, and intervals of PQ and QRS were
not different between the two groups of dogs (Fig. 2A),
but the Q/R ratios in leads II, III, and aVF in the affected
dogs were significantly higher than those in the normal
dogs (Fig. 2B).
Echocardiographic findings
The thickness of LVIDd, IVS, and PW in two CXMDJ (III-
302MA, III-303MA) were not different from those in a
normal littermate (III-301MN) by sequential analysis
with advancing age (Fig. 3A). Those parameters were not
different between other six CXMDJ and three normal dogs,
when examined just before euthanasia (Table 2). FS in III-
302MA decreased with advancing age, and the value
(27.3%) at 21 months of age was lower than that of the
normal littermate, but was within normal range reported
previously [28,29]. FS in the other seven CXMDJ were nor-
mal, even just before euthanasia (Table 2). A mild hypok-
inesis of the left ventricular wall was detected in III-
302MA at 21 months of age (Fig. 3B), but any clinical
signs had not been developed in the dog.
The sequential studies of myocardial echogenicity with
advancing age in III-302MA and in III-303MA demon-
strated that the hyperechoic lesions in the left ventricular
posterior wall were seen at 12 months of age or older (Fig.
4A, Table 3). In the subsequent examinations of six
CXMDJ, we found the hyperechoic lesion in a CXMDJ, III-
D08MA, at 5 months of age (Fig. 4B, Table 3), however
the hyperechoic lesion was not detected in other four
CXMDJ at 5 to 7 months old (Fig. 4B, Table 3). One
CXMDJ, III-D38MA, did not reveal any hyperechoic
lesions when examined at 12 months of age, but has not
been examined at 5 to 7 months of age (Table 3). Taken
these echocardiographic data, it is considered that the car-
diac functions in CXMDJ were basically maintained well
by 21 months of age, despite showing hyperechoic lesions
of the left ventricle in limited numbers of CXMDJ.
Macroscopic and histopathological findings
The right and left ventricular walls were examined macro-
scopically and histopathologically in four normal and
eight affected male dogs at the ages shown in Table 1. The
base view of the formalin-fixed heart did not show any
macroscopic lesions in III-1803MA at 7 months and III-
302MA at 21 months of age (Fig. 5A) like other affected
dogs (data not shown). No histopathological abnormality
was found in the posterior wall of the left ventricle of
Table 1: Clinical profiles of normal and CXMDJ male dogs
Age (mo) BW(g) HW(g) HW/BW (%) Serum CK (IU/I)
Normal dogs
III-D56MN 6 12.0 95.1 0.97 515
III-1804MN 7 13.6 110.0 0.81 215
III-D03MN 14 13.1 127.0 0.84 215
III -301 MN 21 14.4 120.0 0.96 60
CXMDJ dogs
III-D53MA 6 9.6 91.9 0.90 63,100
III-D55MA 7 10.0 80.0 0.80 42,000
III-1803MA 9 14.4 128.6 0.69 69,100
III-D38MA 12 11.4 78.8 1.01 138,000
III-D02MA 15 9.1 92.0 0.87 17,600
III-D08MA 15 12.0 104.3 0.97 40,700
III-302MA 21 12.4 120.0 0.86 12,500
III-303MA 21 13.9 120.0 0.80 23,000
BW, body weight; HW, heart weight; HW/BW, heart weight/body weight ratio; * p < 0.01 normal dogs vs CXMDJ dogsBMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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affected dogs III-1803MA, III-D55MA, and III-D02MA
(Fig. 5B), and other affected dogs under the age of 12
months (III-D53MA, III-D38MA). On the other hand,
moderate fibrosis in the left ventricular wall, especially on
the posterior side, was detected in an affected dog, III-
302MA, at 21 months (Fig. 5B) as well as in III-D08MA at
Electrocardiographic findings in CXMDJ Figure 1
Electrocardiographic findings in CXMDJ A: Sequential studies in electrocardiographic parameters with advancing age in 
normal and CXMDJ dogs. Heart rate (HR) (beats/min), PQ interval (ms), and duration (ms) of QRS complex on ECG in a nor-
mal littermate III-301MN (open circle), and CXMDJ dogs III-302MA (closed circle) and III-303MA (closed square) at 2, 3, 4, 6, 9, 
12, 15, 18, and 21 months of age. B: Representative ECGs in normal and CXMDJ male dogs. ECGs were recorded from normal 
dogs, III-301MN and III-1804MN, and CXMDJ dogs, III-302MA and III-1803MA, at 6 months of age. Distinct deep Q waves were 
present in the CXMDJ dogs. Leads were recorded at 50 mm/s, 1 cm/mV. C: Sequential studies in Q/R ratios with advancing age 
in limb leads I, II, III, and aVF in normal and CXMDJ dogs. Q/R ratios in limb leads I, II, III, and aVF in a normal littermate III-
301MN (open circle), and the CXMDJ dogs III-302MA (closed circle) and III-303MA (closed square) at 2, 3, 4, 6, 9, 12, 15, 18, 
and 21 months of age.BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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Comparison of electrocardiographic parameters and Q/R ratios between normal and CXMDJ dogs at 6–7 months of age Figure 2
Comparison of electrocardiographic parameters and Q/R ratios between normal and CXMDJ dogs at 6–7 
months of age A. Heart rate (HR) (beats/min), PQ interval (ms), and duration of QRS complex (ms) on ECG in normal (n = 
4) and CXMDJ (n = 8) dogs at 6–7 months of age. White columns indicate normal dogs, and black columns represent CXMDJ 
dogs. Bar shows mean +/- SE. B. Q/R ratios in limb leads I (Q/R I), II (Q/R II), III (Q/R III), and aVF (Q/R aVF) on ECG in normal 
(n = 4) and CXMDJ (n = 8) dogs at 6–7 months of age. White columns indicate normal dogs, and black columns represent 
CXMDJ dogs. Bar shows mean +/- SE.BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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Cardiac function by echocardiography in CXMDJ Figure 3
Cardiac function by echocardiography in CXMDJ A: Sequential studies in echocardiographic parameters with advancing 
age in normal and CXMDJ dogs. LVIDd (mm), IVS and PW thickness (mm), and FS (%) in a normal littermate III-301MN (open 
circle), and the CXMDJ dogs III-302MA (closed circle) and III-303MA (closed square) at 2, 3, 4, 6, 9, 12, 15, 18, and 21 months 
of age. B: M-mode echocardiogram in a normal littermate III-301MN, compared to the CXMDJ dog III-302MA at 21 months of 
age. Hypokinesis of the left ventricular posterior wall was observed in the CXMDJ dog.BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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15 months and III-303MA at 21 months of age (data not
shown). We found that the right ventricular walls were
kept intact in all CXMDJ dogs examined.
Discussion
In electrocardiographic findings, an increased HR and a
shortened PQ interval have been reported in both DMD
patients [13] and GRMD [22]. These findings were also
observed in CXMDJ dogs. Increased sympathetic activity
and decreased parasympathetic activity have been
observed in DMD patients and are associated with disease
progression [30]; therefore, autonomic dysfunction in
dystrophin deficiency might affect these parameters. It has
been reported that HR is negatively correlated with PQ
interval in normal Beagle dogs and it may be ascribed to a
parasympathetic input at the level of the AV node [31].
The negative correlation between HR and PQ intervals
was also found in affected dogs, indicating the parasym-
pathetic input was maintained well even in affected dogs
at AV node level. The QRS duration was within normal
limits in the CXMDJ dogs, which is compatible with most
cases of DMD [13]. Another peculiar electrocardiographic
finding in DMD is the deep and narrow Q-waves in I, aVL
and V6 or in II, III and aVF [10,13,16,32]. CXMDJ dogs
also showed prominent Q-waves and increases in the Q/R
ratio in leads II, III, and aVF, findings that are consistent
with those in GRMD [23]. In all CXMDJ dogs examined,
the distinct deep Q-waves were recognized by 6–7 months
of age, which is earlier than the other abnormal electrocar-
diographic parameters, and the Q/R ratio in affected dogs
remained high from 6 to 21 months of age. Actually, the
prominent Q-wave and increase in Q/R ratio were also
detected in some of the CXMDJ dogs at around 2 months
of age (Fig. 1C), but it is difficult to evaluate the degree of
the Q/R ratio increase before 3 months of age because the
QRS vector is almost exclusively directed to the right and
varies significantly in the weeks after birth [33]. A previ-
ous report described GRMD dogs ranging from 6 months
to > 2 years as having deep Q-waves and increased Q/R
ratios in leads II, III, and aVF [23]. The Q-waves, however,
might have been seen earlier and regarded as normal var-
iants or not have been considered important for the rea-
sons mentioned above.
Hyperechoic lesions indicating myocardial fibrosis in the
posterobasal left ventricular wall have been detected by
echocardiography in GRMD dogs as well as DMD patients
[22,23]. Moise et al. reported that hyperechoic lesions
were first detected in eight of eleven GRMD dogs (73%)
by 6–7 months of age and that they correlated with histo-
logically recognizable areas of mineralization and corre-
sponded to the progression of fibrosis [23]. In our study,
one of eight of CXMDJ dogs showed a hyperechoic lesion
in the left ventricular posterior wall, but the rest had not
by the age of 6–7 months (Table 3, Fig. 4). The hypere-
choic lesion in the left ventricular posterior walls was
detected in both III-302MA and III-303MA, but not early
as 12 months of age (Table 3). The results of echocardiog-
raphy indicated that the cardiac involvement in CXMDJ is
milder than that in GRMD. Echocardiography did not
reveal particular left ventricular dysfunction in any
CXMDJ dog by 21 months of age, but a mild hypokinesis
of the left ventricular wall was observed in III-302MA at
21 months of age (Fig. 3B). The dysfunction found in the
dog, however, was mild and the dog had no cardiac symp-
tom. Moise et al. reported that three of the six GRMD dogs
> 2 years of age showed a decrease in fractional shorten-
ing, but did not mention at what age the abnormal cardiac
findings appeared.
Table 2: Echocardiographic findings in normal and CXMDJ male dogs
Age (mo) LVIDd (mm) LVIDs (mm) IVS (mm) PW (mm) FS (%)
Normal male dogs
III-D56MN 6 34.2 12.5 6.6 5.6 63.5
III-1804MN 7 30.7 18.9 8.2 7.4 38.4
III-D03MN 14 32.8 16.8 10.0 9.4 48.7
III-301 MN 21 36.1 23.0 7.0 6.4 36.2
CXMDJ male dogs
III-D53MA 6 29.7 19.7 8.0 7.2 33.8
III-D55MA 7 28.7 15.4 6.3 6.3 46.5
III-1803MA 7 32.5 16.7 5.8 7.5 48.5
III-D38MA 12 30.3 18.8 8.4 5.8 37.8
III-D02MA 15 27.5 17.3 9.1 8.8 37.0
III-D08MA 15 39.5 24.9 5.9 5.9 36.9
III-302MA 21 32.9 23.9 6.4 6.1 27.3
III-303MA 21 37.6 23.1 6.2 5.7 38.6
Age, age at examination; LVIDd, LV internal dimension diastolic; LVIDs, LV internal dimension systolic; IVS, intraventricular septum thickness; PW, 
posterior wall thickness; FS, fractional shorteningBMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
Page 9 of 13
(page number not for citation purposes)
Previous studies of morphology in GRMD showed that
myocardial involvement is initially found in the left pos-
terobasal ventricular wall, similar to that of patients with
DMD [21-23]. Valentine et al. reported that GRMD dogs
Echogenicity in CXMDJ Figure 4
Echogenicity in CXMDJ A: Sequential studies in echogenicity with advancing age by two-dimensional echocardiography in a 
normal dog III-301MN, and a CXMDJ dog III-302MA, at 6–21 months of age. Hyperechoic lesions (arrowheads) of the left ven-
tricular posterior wall were detected in the CXMDJ dog at 12 months of age and older.B: Two-dimensional echocardiograms 
of a normal dog III-301MN at 6 months of age, and four CXMDJ dogs III-D53MA, III-D55MA, III-1803MA, and III-D08MA at 6 
to 7 months of age. The hyperechoic lesion (arrowhead) was detected only in the left ventricular posterior wall of III-D08MA.BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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at 6.5 months of age had acute severe lesions with focal
myocardial mineralization associated macrophages and
giant cells in the left ventricular papillary muscle and left
ventricular wall [22]. Moreover, GRMD dogs at 12
months of age or older demonstrated prominent myocar-
dial fibrosis in more widespread lesions [22]. The myocar-
dial fibrosis of the left ventricular wall in the older stage of
CXMDJ dogs was consistent with that in DMD patients
and GRMD dogs. The change was detected at 15 months
of age or older in the CXMDJ (III-D08MA, III-302MA, and
III-303MA), although III-D08MA showed a hyperechoic
lesion at 5 months of age or older (Table 3). The cardiac
involvement in CXMDJ, therefore, was milder and slowly
progressed than that in GRMD, although a longer period
evaluation of large numbers of CXMDJ will be needed to
conclude the mild cardiac phenotypes of CXMDJ.
Why is the cardiac involvement in CXMDJ milder than
that in GRMD? Valentine et al. reported that skeletal mus-
cle involvement in small dystrophic dogs was milder than
that in large ones [19]. Several reports on dystrophic fea-
tures have hypothesized that the clinical severity may be
associated with growth rate [34] or muscle fiber diameter
[35]. Living in a cage rather than running free could also
affect the cardiac phenotypes of CXMDJ because physical
exercise promotes cardiac involvement in dystrophin-
deficient  mdx  mice [36]. The difference in the genetic
background between GRMD, golden retriever and
CXMDJ, Beagle might also affect the disease progression.
The prominent deep Q-waves seen in both DMD and
GRMD have been attributed to a reduction in or a loss of
electromotive force caused by scarring of the posterobasal
region of the left ventricle [8,9,17]. In our study, the deep
Q-waves and increases in the Q/R ratio in CXMDJ pre-
ceded the lesions seen on echocardiogram and histopa-
thology, as shown in Fig. 6. Considering this result, the
origin of the distinctive Q-waves might not be associated
with the myocardial lesion in the posterobasal left ven-
tricular wall. It has recently been reported that expression
of a transgene in mdx mice for neuronal nitric oxide syn-
thase (nNOS), which occurs as a secondary loss in dys-
trophin deficiency, decreased cardiac inflammation and
fibrosis resulting in amelioration of both cardiac function
and electrocardiographic abnormalities, including deep
Q-waves [37]. Perloff et al. suggested that the alteration of
a particular ionic current by lack of specific membrane
proteins associated with dystrophin might participate in
electrocardiographic changes [17]. We will not therefore
deny that minimal myocardial damage could be associ-
ated with the pathogenesis of deep Q-waves, but our
results suggest that an investigation of the conduction and
cardiovascular systems will also be needed to explore the
pathophysiology of the deep Q-waves in dystrophin-defi-
cient heart. In this regard, CXMDJ will be very useful to
elucidate aspects of the dystrophin-deficient heart, but we
may recognize that a longer period of time would be
required to complete cardiac phenotypes in CXMDJ.
Conclusion
We demonstrated that the cardiac phenotypes of CXMDJ
are comparable to but milder than those of GRMD. Fur-
thermore, we found for the first time that the distinct deep
Q-waves precede detection of the left ventricular postero-
basal lesion by echocardiography or histopathology.
CXMDJ may provide not only new insights into the mech-
Table 3: Echogenicity of left ventricular posterior wall in normal and CXMDJ male dogs
Months of age (mo)
2 3 4 5 6 7 8 9 1 01 1 1 2 1 3 1 4 1 5 1 61 71 81 92 0 2 1
Normal dogs
III-D56MN (-)*
III-1804MN (-) (-)*
III-D03MN (-) (-) (-) (-) (-) (-)*
III-301 MN (-) (-) (-) (-) (-) (-) (-) (-) (-)*
CXMDJ dogs
III-D53MA (-)*
III-D55MA (-) *
III-1803MA (-) (-)*
III-D38MA (-)*
III-D02MA (-) (-) (-) (-) (-) (-)*
III-D08MA (-) (+) (+) (+) (+) (+)*
III-302MA (-) (-) (-) (-) (-) (+) (+) (+) (+)*
III-303MA (-) (-) (-) (-) (-) (+) (+) (+) (+)*
Hyperechoic lesion +, positive; -, negative; Asterisk in each CXMDJ dog shows age at euthanasia.BMC Cardiovascular Disorders 2006, 6:47 http://www.biomedcentral.com/1471-2261/6/47
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anisms causing the abnormal Q-waves but also more
information on the pathogenesis in the dystrophin-defi-
cient heart.
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